What human papillomavirus (HPV) type is a 26-year-old woman with high-grade squamous intraepithelial lesions (HSIL) on her Pap (Papanicolaou) smear most likely infected with?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HPV Type Most Likely Associated with HSIL in a 26-Year-Old Woman

HPV 16 is the most likely type of human papillomavirus causing high-grade squamous intraepithelial lesions (HSIL) in this 26-year-old woman with multiple risk factors.

Epidemiology and Association of HPV Types with HSIL

HPV 16 is strongly associated with HSIL and cervical cancer development for several reasons:

  • HPV 16 accounts for approximately 50-60% of invasive squamous cell carcinomas worldwide 1
  • In patients with HSIL, HPV 16 is detected in 53.1% of cases, making it the most common HPV type found in high-grade lesions 2
  • HPV 16 is uniquely associated with cervical intraepithelial neoplasia Grade 3 or worse (CIN3+), is most likely to persist, and has the highest probability of progressing to higher-grade lesions 1
  • The prevalence of HPV 16 is significantly higher in HSIL (60.7%) compared to lower-grade abnormalities like LSIL (23.6%) and ASC-US (13.3%) 1

Risk Factors Present in This Patient

This 26-year-old woman has several risk factors that increase her likelihood of HPV 16 infection and HSIL:

  • Multiple sexual partners since age 18
  • Tobacco use disorder (smoking is a known cofactor for HPV persistence and progression)
  • Lack of gynecologic care for over 5 years (missed opportunity for early detection)

HPV Types and Their Association with Cervical Lesions

Different HPV types have varying associations with cervical lesions:

  • HPV 16,18,31,33: High-risk types associated with HSIL and cervical cancer

    • HPV 16: Most common in HSIL (53.1%) 2
    • HPV 18: Found in 10.3% of HSIL cases 2
    • HPV 31/33: Found in 8% of HSIL cases 2
  • HPV 6,11: Low-risk types primarily associated with genital warts and rarely with HSIL

    • Only found in 2.96% of HSIL cases 2
    • Progression to HSIL is not found in patients with low-risk HPV 6 and 11 infection 3

Clinical Implications

The identification of HPV 16 in this patient has important clinical implications:

  • The CDC recommends colposcopy for any HPV 16 or 18 positive result regardless of cytology due to the significantly increased risk of cervical precancerous lesions 4
  • Women infected with HPV 16 have more frequent progression of lesions to higher-grade HSIL and should be intensively monitored because of the increased risk for development of cervical carcinoma 3
  • HPV 16 carries a 17-21% risk for CIN3+ development, which is significantly higher than other HPV types 4

Diagnostic Considerations

While HPV testing is highly valuable, there are important caveats to consider:

  • A small percentage (8.3%) of HSIL cases can be HPV negative despite histological confirmation 5
  • Type-specific viral load may be a powerful diagnostic marker for HSIL+ in HPV 16-infected lesions 6
  • HPV negative HSIL is more common in older women (mean age 49.3 years) compared to HPV positive HSIL (mean age 40.7 years) 7

Given the patient's age, risk factors, and HSIL finding on liquid-based cytology, HPV 16 is the most likely causative agent in this case.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.